ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

CMPS vs STOK // REVENUE GROWTH (YOY)

COMPASS Pathways Plc American Depository Shares (NASDAQ) VS. Stoke Therapeutics Inc. (NASDAQ) • 15-METRIC TALLY: CMPS 0 — STOK 5
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CMPS VS. STOK) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC CMPS STOK SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -6.10% -28.90 STOK /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -9.31% 2.64% -11.95 STOK /fcf-yield <GO>
Operating Margin — -11.20% — TIE /operating-margins <GO>
Net Profit Margin — -3.70% — TIE /net-margins <GO>
Revenue Growth (YoY) ACTIVE — 180.00% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 14.79 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 1/9 6/9 -5.00 STOK /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 51.5 52.7 -1.20 STOK /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $1.69B $1.70B -$12.2M STOK /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR CMPS REV STOK REV CMPS GROSS % STOK GROSS % CMPS FCF STOK FCF
FY 2025 $0 $184.4M — — -$157.2M $44.9M
FY 2024 $0 $36.6M — — -$119.2M -$87.1M
FY 2023 $0 $8.8M — — -$97.4M -$81.1M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CMPS // BETA —
STOK // BETA —